From: Fibrosis and bone marrow: understanding causation and pathobiology
I. Generalized myelofibrosis: |
Neoplastic / Clonal disorders |
Chronic idiopathic myelofibrosis* (myelofibrosis with myeloid metaplasia; also known as agnogenic myeloid metaplasia) |
Myelofibrosis secondary to essential thrombocythaemia or polycythaemia rubra vera* |
Chronic myeloid leukaemia* |
Acute megakaryoblastic leukaemia* |
Other acute myeloid leukaemias |
Acute lymphoblastic leukaemia |
Systemic mastocytosis* |
Myelodysplastic syndromes (particularly secondary MDS) |
Myelofibrotic myelodysplastic syndrome (Pagliucaet al, 1989) |
Acute panmyelosis with myelofibrosis |
Paroxysmal nocturnal haemoglobinuria |
Hodgkin lymphoma |
Non-Hodgkin lymphoma |
Plasma cell myeloma |
Metastatic tumours |
Bone and connective tissue diseases* |
 Osteopetrosis |
 Primary and secondary hyperparathyroidism |
 Nutritional and renal rickets (vitamin D deficiency) |
 Osteomalacia |
 Primary hypertrophic osteoarthropathy |
 Pachydermoperiostosis |
 Miscellaneous conditions |
 Tuberculosis |
  Other granulomatous diseases |
  Grey platelet syndrome |
  Systemic lupus erythematosus |
  Systemic sclerosis |
  Sjogren syndrome |
  Primary autoimmune myelofibrosis |
   Antiphospholipid antibodies |
  Other autoimmune myelofibrosis |
   Prior thorium dioxide administration |
  II. Focal or localized fibrosis |
   Osteomyelitis |
   Paget’s disease |
   Following bone marrow necrosis |
   Following irradiation of the bone marrow |
   Adult T-cell leukaemia/lymphoma |
   Healing fractureSite of previous trephine biopsy* |